Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retrospective analysis of gemcitabine and oxaliplatin (GemOx)-based treatment in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Schade, J. R.; Kim, C.; Drill, E.; Qiu, A.; Batlevi, C. L.; Caron, P.; Colbourn, D. S.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Sparing of the lower gastrointestinal tract microbiota is associated with reduced acute graft-versus-host disease
    Meeting Abstract

    Ponce, D. M.; Burgos da Silva, M. D.; Gomes, A. L. C.; Moore, G.; Slingerland, J. B.; Pamer, E. G.; Taur, Y.; Peled, J. U.; van den Brink, M. R. M.
    Blood (2019)

    Fulltext@MSK | Save
  • VTE rates and safety analysis of newly diagnosed multiple myeloma patients receiving carfilzomib-lenalidomide-dexamethasone (KRD) with or without rivaroxaban prophylaxis
    Meeting Abstract

    Piedra, K. M.; Hassoun, H.; Buie, L. W.; Devlin, S. M.; Flynn, J.; Hultcrantz, M.; Lesokhin, A. M.; Lu, S. X.; Mailankody, S.; Shah, U. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • An observational, retrospective analysis of retreatment with carfilzomib in the management of patients with multiple myeloma
    Meeting Abstract

    Peterson, T. J.; Korde, N.; Hassoun, H.; Mailankody, S.; Lesokhin, A. M.; Hultcrantz, M.; Shah, U. A.; Smith, E. L.; Lu, S. X.; Landau, H. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • PD-L1 checkpoint blockade augments anti-tumor immune response of GD2 or HER2-BsAb ex vivo armed T-cells (EVAT) therapy in osteosarcoma
    Meeting Abstract

    Park, J. A.; Guo, H. F.; Xu, H.; Cheung, N. K. V.
    Blood (2019)

    Fulltext@MSK | Save
  • Molecular characteristics that predict response to azacitidine therapy
    Meeting Abstract

    Nannya, Y.; Tobiasson, M.; Bernard, E.; Sato, S.; Creignou, M.; Takeda, J.; Zhao, L.; Shiraishi, Y.; Chiba, K.; Tanaka, H.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Final results of a phase II biomarker-driven study of ruxolitinib in relapsed and refractory T-cell lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E. D.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Hancock, H.; Davey, T.; Obadi, O.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • High complete response rate observed with second-line chemo-immunotherapy with pembrolizumab and GVD (gemcitabine, vinorelbine, and liposomal doxorubicin) in relapsed and refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G. L.; Schoder, H.; Hancock, H.; Davey, T.; Joong, C.; Pomerantz, L.; Jarjies, C.; Kumar, A.; Lahoud, O. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Inhibition of PIM kinases targets synthetic vulnerabilities and enhances antigen presentation in B-cell lymphoma
    Meeting Abstract

    Mondello, P.; Tarantelli, C.; Cascione, L.; Arribas, A.; Rinaldi, A.; Younes, A.; Bertoni, F.
    Blood (2019)

    Fulltext@MSK | Save
  • ABVD versus escalated BEACOPP in advanced stage Hodgkin's lymphoma: Results from a retrospective, multicenter European study
    Meeting Abstract

    Mondello, P.; Dogliotti, I.; Bohn, J. P.; Cavallo, F.; Ferrero, S.; Botto, B.; Cerchione, C.; Nappi, D.; De Lorenzo, S.; Martinelli, G.; more...
    Blood (2019)

    Fulltext@MSK | Save